Functional redundancy of transcription factor-binding sites in the killer cell Ig-like receptor (KIR) gene promoter

International Immunology

Volumn 18, Issue 8, 2006, Pages 1221-1232

  Presnell, Steven R ^a   Zhang, Lei ^a   Ramilo, Cecilia A ^a   Chan, Huei Wei ^a   Lutz, Charles T ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Gene regulation; Human; Molecular biology; NK cells; Transcription factors

Indexed keywords

CYCLIC AMP; CYTOKINE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; STAT5 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; BINDING SITE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE MUTATION; GENETIC TRANSFECTION; NATURAL KILLER CELL; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; CORE BINDING FACTOR ALPHA SUBUNITS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-ETS; RECEPTORS, IMMUNOLOGIC; SP1 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; YY1 TRANSCRIPTION FACTOR;

EID: 33748460287     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl043     Document Type: Article

References (33)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
2. Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22:633.
3. Lanier, L. L., Corliss, B. and Phillips, J. H. 1997. Arousal and inhibition of human NK cells. Immunol. Rev. 155:145.
4. Wilson, M. J., Torkar, M., Haude, A. et al. 2000. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl Acad. Sci. USA 97:4778.
5. Valiante, N. M., Uhrberg, M., Shilling, H. G. et al. 1997. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7:739.
6. Chan, H. W., Kurago, Z. B., Stewart, C. A. et al. 2003. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J. Exp. Med. 197:245.
7. Chan, H. W., Miller, J. S., Moore, M. B. and Lutz, C. T. 2005. Epigenetic control of highly homologous killer Ig-like receptor gene alleles. J. Immunol. 175:5966.
8. Santourlidis, S., Trompeter, H. I., Weinhold, S. et al. 2002. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 169:4253.
9. Trompeter, H.-I., Gómez-Lozano, N., Santourlidis, S. et al. 2005. Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J. Immunol. 174:4135.
10. van Bergen, J., Stewart, C. A., van den Elsen, P. J. and Trowsdale, J. 2005. Structural and functional differences between the promoters of independently expressed killer cell Ig-like receptors. Eur. J. Immunol. 35:2191.
11. Xu, J., Vallejo, A. N., Jiang, Y., Weyand, C. M. and Goronzy, J. J. 2005. Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells. J. Biol. Chem. 280:24277.
12. Yodoi, J., Teshigawara, K., Nikaido, T. et al. 1985. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J. Immunol. 134:1623.
13. Sambrook, J., Fritsch, E. F. and Maniatis, T. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
14. Zhu, M., John, S., Berg, M. and Leonard, W. J. 1999. Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNγ-mediated signaling. Cell 96:121.
15. Smith, K. D., Valenzuela, A., Vigna, J. L., Aalbers, K. and Lutz, C. T. 1993. Unwanted mutations in PCR mutagenesis: Avoiding the predictable. PCR Methods Appl. 2:253.
16. Karantzoulis-Fegaras, F., Antoniou, H., Lai, S.-L. M. et al. 1999. Characterization of the human endothelial nitric-oxide synthase promoter. J. Biol. Chem. 274:3076.
17. Aγ-globin gene. J. Biol. Chem. 270:12892.
18. Stewart, C. A., Van Bergen, J. and Trowsdale, J. 2003. Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. J. Immunol. 170:6073.
19. Radeloff, B., Nagler, L., Zirra, M., Ziegler, A. and Volz, A. 2005. Specific amplification of cDNA ends (SPACE): A new tool for the analysis of rare transcripts and its application for the promoter analysis of killer cell receptor genes. DNA Seq. 16:44.
20. Bassuk, A. G. and Leiden, J. M. 1997. The role of Ets transcription factors in the development and function of the mammalian immune system. Adv. Immunol. 64:65.
21. Stacey, K. J., Fowles, L. F., Colman, M. S., Ostrowski, M. C. and Hume, D. A. 1995. Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. Mol. Cell. Biol. 15:3430.
22. Arman, M., Calvo, J., Trojanowska, M. E. et al. 2004. Transcriptional regulation of human CD5: Important role of Ets transcription factors in CD5 expression in T cells. J. Immunol. 172:7519.
23. Hollenhorst, P. C., Jones, D. A. and Graves, B. J. 2004. Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res. 32:5693.
24. Schug, J. 2003. Using TESS to predict transcription factor binding sites in DNA sequence. In Baxevanis, A. D., Davison, D. B., Page, R. D. M., Petsko, G. A., Stein, L. D. and Stormo, G. D., eds., Current Protocols in Bioinformatics, p. 2.6.1. Greene Publishing Associates and Wiley-Interscience, New York.
25. Gilmour, K. C., Pine, R. and Reich, N. C. 1995. Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc. Natl Acad. Sci. USA 92:10772.
26. Barthel, R., Tsytsykova, A. V., Barczak, A. K. et al. 2003. Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300. Mol. Cell. Biol. 23:526.
27. Maniatis, T., Falvo, J. V., Kim, T. H. et al. 1998. Structure and function of the interferon-b enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 63:609.
28. Lian, J. B., Stein, J. L., Stein, G. S. et al. 2003. Runx2/Cbfa1 functions: Diverse regulation of gene transcription by chromatin remodeling and co-regulatory protein interactions. Connect. Tissue Res. 44(Suppl. 1):141.
29. Meier, V. S. and Groner, B. 1994. The nuclear factor YY1 participates in repression of the b-casein gene promoter in mammary epithelial cells and is counteracted by mammary gland factor during lactogenic hormone induction. Mol. Cell. Biol. 14:128.
30. Bergad, P. L., Towle, H. C. and Berry, S. A. 2000. Yin-yang 1 and glucocorticoid receptor participate in the Stat5-mediated growth hormone response of the serine protease inhibitor 2.1 gene. J. Biol. Chem. 275:8114.
31. Cirillo, L. A., Lin, F. R., Cuesta, I., Friedman, D., Jarnik, M. and Zaret, K. S. 2002. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 9:279.
32. Miller, J. S. and McCullar, V. 2001. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood 98:705.
33. Ye, S. K., Agata, Y., Lee, H. C. et al. 2001. The IL-7 receptor controls the accessibility of the TCRc locus by Stat5 and histone acetylation. Immunity 15:813.